Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

390 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancer.
Haas R, Schmid H, Hahn U, Hohaus S, Goldschmidt H, Murea S, Kaufmann M, Wannenmacher M, Wallwiener D, Bastert G, Hunstein W. Haas R, et al. Among authors: wannenmacher m. Eur J Cancer. 1997 Mar;33(3):372-8. doi: 10.1016/s0959-8049(97)89008-9. Eur J Cancer. 1997. PMID: 9155519 Clinical Trial.
390 results